Showing results (931-940 of 1,036) with videos related to
Sort By:
Pageof 104
The Annals of Thoracic Surgery|November 5, 2011
Lobectomy versus sublobar resection for small (2 cm or less) non-small cell lung cancersAndrea S Wolf, William G Richards, Michael T Jaklitsch, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2006
Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesotheliomaWilliam G Richards, Lambros Zellos, Raphael Bueno, et al.BMC Public Health|February 9, 2024
Study protocol of a randomized controlled trial to assess the efficacy of the "PrEPare for Work" intervention to enhance PrEP uptake and optimize adherence for HIV prevention among male sex workers in the U.SKatie B Biello, Philip A Chan, Colleen D Ndoye, et al.Annals of Surgery|September 1, 1996
Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patientsD J Sugarbaker, J P Garcia, W G Richards, et al.Journal of the National Cancer Institute|April 30, 2009
Four-gene expression ratio test for survival in patients undergoing surgery for mesotheliomaGavin J Gordon, Lingsheng Dong, Beow Y Yeap, et al.Pediatrics|July 21, 2010
Prevalence and complications of single-gene and chromosomal disorders in craniosynostosisAndrew O M Wilkie, Jo C Byren, Jane A Hurst, et al.Molecular Oncology|July 6, 2016
Low Merlin expression and high Survivin labeling index are indicators for poor prognosis in patients with malignant pleural mesotheliomaMayura Meerang, Karima Bérard, Martina Friess, et al.The Journal of Thoracic and Cardiovascular Surgery|July 22, 2009
Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective studyTamara R Tilleman, William G Richards, Lambros Zellos, et al.Journal of Neurochemistry|November 18, 2000
Characterization of [(3)H]Quisqualate binding to recombinant rat metabotropic glutamate 1a and 5a receptors and to rat and human brain sectionsV Mutel, G J Ellis, G Adam, et al.The Journal of Antimicrobial Chemotherapy|January 22, 2017
Therapeutic drug monitoring and use of an adjusted body weight strategy for high-dose voriconazole therapyPatrick G Richards, Kimberlyn M Dang, Carol A Kauffman, et al.Pageof 104